Featured Research

from universities, journals, and other organizations

Hypertension And Atherosclerosis May Have A Common Cause, Researchers Say

Date:
November 15, 1999
Source:
Wake Forest University Baptist Medical Center
Summary:
The same hormone that causes high blood pressure may promote the development of atherosclerosis, reported researchers from Wake Forest University Baptist Medical Center at the national meeting of the American Heart Association.

WINSTON-SALEM, N.C. - The same hormone that causes high blood pressure may promote the development of atherosclerosis, reported researchers from Wake Forest University Baptist Medical Center today (Nov. 9) at the national meeting of the American Heart Association.

Related Articles


The researchers said the protein Angiotensin II, which causes a narrowing of small blood vessels and raises blood pressure, may also promote the buildup of fatty deposits in the arteries of people with high cholesterol.

"It's possible that to prevent the development of plaque buildup, we need to treat not only cholesterol, but to treat the hormone that has been linked to hypertension," said Carlos Ferrario, M.D., director of the Hypertension and Vascular Disease Center, who presented the findings.

In a study of cymomolgus monkeys fed a high-fat diet, the researchers found that the anti-hypertensive drug Losartan inhibited the development of atherosclerosis by 50 percent compared to monkeys that didn't receive the drug.

The monkeys, who did not have hypertension, were selected for study because they have marked similarities to humans in the development of cardiovascular disease.

This was the first study to demonstrate that a drug used to block Angiotensin II and control blood pressure can prevent or slow down the development of atherosclerosis. Researchers believe the effect was caused by the drug's ability to protect low-density lipoproteins, the so-called "bad" cholesterol, from oxidization. Oxidation increases the toxic effect of lipoprotein on arteries.

"These results imply that we should be more aggressive in treating patients with hypertension who are at risk for atherosclerosis," Ferrario said. "They suggest that treatment of hypertension with drugs that selectively block the actions of Angiotensin II will slow down or prevent the development of atherosclerosis."

Ferrario said the results are too preliminary to begin treating non-hypertensive patients with the drug. He said future treatment for patients who have high cholesterol and are at risk for heart attack might include both lipid-lowering and anti-hypertensive drugs. Ferrario called for additional research to duplicate the findings in humans and to understand the mechanisms that cause hypertension and atherosclerosis.

Other members of the research team were William B. Strawn, D.V.M., Mark C. Chappell, Ph.D., and Richard H. Dean, M.D., from the Medical Center and Salah Kivlighn, Ph.D., from Merck & Co., which manufactures Losartan and funded the research.


Story Source:

The above story is based on materials provided by Wake Forest University Baptist Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Wake Forest University Baptist Medical Center. "Hypertension And Atherosclerosis May Have A Common Cause, Researchers Say." ScienceDaily. ScienceDaily, 15 November 1999. <www.sciencedaily.com/releases/1999/11/991115070149.htm>.
Wake Forest University Baptist Medical Center. (1999, November 15). Hypertension And Atherosclerosis May Have A Common Cause, Researchers Say. ScienceDaily. Retrieved March 2, 2015 from www.sciencedaily.com/releases/1999/11/991115070149.htm
Wake Forest University Baptist Medical Center. "Hypertension And Atherosclerosis May Have A Common Cause, Researchers Say." ScienceDaily. www.sciencedaily.com/releases/1999/11/991115070149.htm (accessed March 2, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 2, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com
Doctors Often Give In To Vaccine-Wary Parents

Doctors Often Give In To Vaccine-Wary Parents

Newsy (Mar. 2, 2015) A new survey published in the journal Pediatrics found many doctors are giving in to parents&apos; requests to delay vaccinating their children. Video provided by Newsy
Powered by NewsLook.com
The Best Ways To Celebrate National Nutrition Month

The Best Ways To Celebrate National Nutrition Month

Buzz60 (Mar. 2, 2015) Just when your New Year&apos;s Resolution is losing steam, March comes with fresh inspiration. TC Newman (@PurpleTCNewman) has some tips to incorporate into your lifestyle during National Nutrition Month. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins